Clinical features of polymyalgia rheumatica patients in Japan: Analysis of real-world data from 2015 to 2020
Modern Rheumatology · 2023
DOI: 10.1093/mr/road026 ↗Kurz gefasst
Fachartikel in der Zeitschrift Modern Rheumatology, 2023. Verfasst von Yoshiya Tanaka und 3 weiteren Autor:innen. Beteiligte Einrichtung: The First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Japan, Kitakyushu, Japan. Hauptthemen laut MEDLINE: Giant Cell Arteritis, Polymyalgia Rheumatica. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 41 Literaturangaben.
Abstract (Originalsprache)
Objectives
To assess clinical features in patients with polymyalgia rheumatica (PMR) in Japan by the International Classification of Disease (ICD)-10 code assignment.
Methods
Demographics, treatment patterns, and concomitant diseases (identified using ICD-10 code only) in patients who were assigned the PMR ICD-10 code M35.3 at least once between 1 January 2015 and 31 December 2020 were aggregated from a nationwide medical information database owned by the Health, Clinic, and Education Information Evaluation Institute.
Results
The cumulative number of patients with PMR was 6325 (mean [standard deviation] age, 74.3 [11.4] years; male:female, 1:1.3). Most patients were >50 years (96.5%) with >33% between 70 and 79 years. Glucocorticoids were prescribed in ∼54% of patients within 30 days of PMR code assignment. All other drug types were prescribed in <5% of patients. Hypertension, diabetes mellitus, rheumatoid arthritis, and osteoporosis were noted in >25% and giant cell arteritis in 1% of patients. During the study period, 4075 patients were newly assigned the PMR code and 62% were prescribed glucocorticoids within 30 days.
Conclusions
This is the first retrospective real-world data analysis describing the clinical features of PMR in a large patient population from Japan. Further studies of prevalence, incidence, and clinical features are warranted in patients with PMR.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Japan, Kitakyushu, Japan.
- Medical Affairs Department, Asahi Kasei Pharma Corporation, Tokyo, Japan.
- Specialty Care Medical, Sanofi K.K., Tokyo, Japan.
Zitieren
APA
Tanaka, Y., Tanaka, S., Takahashi, T., & Kato, N. (2023). Clinical features of polymyalgia rheumatica patients in Japan: Analysis of real-world data from 2015 to 2020. Modern Rheumatology. https://doi.org/10.1093/mr/road026
Vancouver
Tanaka Y, Tanaka S, Takahashi T, Kato N. Clinical features of polymyalgia rheumatica patients in Japan: Analysis of real-world data from 2015 to 2020. Modern Rheumatology. 2023. doi:10.1093/mr/road026
BibTeX
@article{Tanaka2023,
author = {Tanaka, Yoshiya and Tanaka, Shinichi and Takahashi, Toshiya and Kato, Naoto},
title = {Clinical features of polymyalgia rheumatica patients in Japan: Analysis of real-world data from 2015 to 2020},
journal = {Modern Rheumatology},
year = {2023},
doi = {10.1093/mr/road026}
}
EUVIMED